Emi E. Nakayama - Concepedia

Author

Emi E. Nakayama

Also Known As

E Nakayama, E. E. Nakayama, E. Nakayama, E.E. Nakayama, EHCHI NAKAYAMA, Emi E Nakayama, Emi E. Nakayama, Emi NAKAYAMA, Emi Nakayama, Emi. E. Nakayama

176

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Osaka National Institute of Infectious Diseases Mahidol University Mahidol Oxford Tropical Medicine Research Unit Ministry of Public Health

About

Emi E. Nakayama is an author at The University of Osaka specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	35	1.4K
2	Public Health	6	6	170
3	Allergy	3	3	217
4	Engineering	1	1	20
5	Natural Sciences	1	1	24

Emi E. Nakayama

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression Huanliang Liu, David Chao, Emi E. Nakayama, Proceedings of the National Academy of Sciences	1999	334
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies Yafei Liu, Wai Tuck Soh, Jun-ichi Kishikawa, Cell Vaccine TargetViral PathogenesisImmunologyInfectivity-enhancing SiteVirology	2021	285
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage Tatsuo Shioda, Hiroyuki Kato, Yukano Ohnishi, Proceedings of the National Academy of Sciences ImmunologyImmune RegulationImmunodominanceImmunologic MechanismChemotactic Activities	1998	180
A Specific Region of 37 Amino Acid Residues in the SPRY (B30.2) Domain of African Green Monkey TRIM5α Determines Species-Specific Restriction of Simian Immunodeficiency Virus SIVmac Infection Emi E. Nakayama, Hiroyuki Miyoshi, Yoshiyuki Nagai, Journal of Virology	2005	121
Polymorphism in the Interleukin-4 Promoter Affects Acquisition of Human Immunodeficiency Virus Type 1 Syncytium-Inducing Phenotype Emi E. Nakayama, Yoshihiko Hoshino, Xiaomi Xin, Journal of Virology	2000	93
Discovery of a small molecule inhibitor targeting dengue virus NS5 RNA-dependent RNA polymerase Hideaki Shimizu, Akatsuki Saito, Junko Mikuni, PLoS neglected tropical diseases	2019	89
Cytokine Expression in Dengue Fever and Dengue Hemorrhagic Fever Patients with Bleeding and Severe Hepatitis Hisham Ahmed Imad, Weerapong Phumratanaprapin, Benjaluck Phonrat, American Journal of Tropical Medicine and Hygiene ImmunologySevere HepatitisConfirmed Dengue InfectionImmune SystemArbovirus	2020	74
HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients Sirirat Likanonsakul, Tippawan Rattanatham, Siriluk Feangvad, AIDS Research and Therapy	2009	72
Protective Effect of Interleukin‐4 −589T Polymorphism on Human Immunodeficiency Virus Type 1 Disease Progression: Relationship with Virus Load Emi E. Nakayama, Laurence Meyer, Aikichi Iwamoto, The Journal of Infectious Diseases	2002	72
The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN Wai Tuck Soh, Yafei Liu, Emi E. Nakayama, Humoral ResponseViral PathogenesisImmunologyViral Structural ProteinVirus Structure	2020	72

Page 1